Charles K. Dargan - 30 Jun 2022 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Financial Officer
Signature
/s/ John R. Browning, Attorney-in-fact
Issuer symbol
BLGO
Transactions as of
30 Jun 2022
Net transactions value
$0
Form type
4
Filing time
05 Jul 2022, 17:35:59 UTC
Previous filing
04 Apr 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to purchase common stock Award $0 +150,000 +3.7% $0.000000 4,236,500 30 Jun 2022 Common stock 150,000 $0.1800 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was granted to Reporting Person to replace option(s) previously issued in lieu of cash compensation to Reporting Person for services provided to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price of the Option and the current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.
F2 Total reflects the expiration of an option to purchase 300,000 shares at $0.35 issued in 2012 to Reporting Person.